Smith Jason Drew Insider Trading Activity

Corporate InsiderGeneral Counsel · CIK 1821479

5

Total trades

$320K

Total volume

Feb 3, 2026

Last activity

URGN

UroGen Pharma Ltd.

Smith Jason Drew has been net-selling over the last 12 months with 0 purchases and 3 sales across 1 company.

URGN is the most-traded position with 3 trades. The largest single transaction was a sale of URGN for $63K on Feb 3, 2026.

Performance Scorecard

Forward stock performance after each transaction by Smith Jason Drew. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days—+1.7%80%5
90 days—-16.9%0%5
120 days—-32.9%0%5

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

URGN · UroGen Pharma Ltd.

🔒 Subscribe to see trade entries

Pro members see exactly when Smith Jason Drew bought and sold URGN.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEΔ OWNEDROLEFILING
Feb 3, 2026
⚠ Filed 6d late
URGNSell2,654$19.69$52K−4.8%General Counsel
Feb 3, 2026
⚠ Filed 6d late
URGNSell1,608$19.69$32K−3.0%General Counsel
Feb 3, 2026
⚠ Filed 6d late
URGNSell3,217$19.69$63K−5.5%General Counsel
Sep 8, 2025
URGNSell1,520$19.11$29K−3.4%General Counsel
Jul 28, 2025
URGNSell7,522$19.14$144K−15.3%General Counsel

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
URGNUroGen Pharma Ltd.5$320K

Other insiders at UroGen Pharma Ltd.

1 other tracked filer at URGN.